Venus Remedies Ltd

Venus Remedies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Venus Remedies Ltd

₹ 170 4.50%
22 Mar - close price
venusremedies.com BSE: 526953 NSE : VENUSREM
About

Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical products manufacturing.[1]

Key Points

Therapeutic Areas
The company manufactures and sells a very wide range of pharmaceutical products in therapeutic segments like Anti-infective (antibiotics), oncology, neurology, pain management, skin & wound care, anti-microbial resistance, etc.[1]

Website BSE NSE
  • Market Cap ₹ 227 Cr.
  • Current Price ₹ 170
  • High / Low ₹ 380 / 145
  • Stock P/E 14.4
  • Book Value ₹ 337
  • Dividend Yield 0.00 %
  • ROCE 8.01 %
  • ROE 9.85 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Stock is trading at 0.50 times its book value
  • Company has delivered good profit growth of 34.4% CAGR over last 5 years
  • Company's working capital requirements have reduced from 108 days to 85.2 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low
  • Company has a low return on equity of 6.92% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
96.86 83.06 188.75 126.07 121.94 111.37 129.81 202.56 124.34 141.93 143.08 139.89 116.90
86.06 75.53 168.21 115.42 103.86 106.88 112.99 175.25 111.91 136.39 128.57 126.92 108.80
Operating Profit 10.80 7.53 20.54 10.65 18.08 4.49 16.82 27.31 12.43 5.54 14.51 12.97 8.10
OPM % 11.15% 9.07% 10.88% 8.45% 14.83% 4.03% 12.96% 13.48% 10.00% 3.90% 10.14% 9.27% 6.93%
1.77 -7.44 -7.13 19.87 6.29 24.05 1.96 2.89 1.22 2.25 1.44 1.79 3.81
Interest 4.07 -1.82 2.85 7.39 1.81 0.96 0.14 0.03 0.31 0.00 0.26 0.00 0.15
Depreciation 8.48 6.47 8.59 8.61 8.70 9.38 8.62 8.71 8.64 7.56 7.80 8.99 7.22
Profit before tax 0.02 -4.56 1.97 14.52 13.86 18.20 10.02 21.46 4.70 0.23 7.89 5.77 4.54
Tax % 4,950.00% -17.98% 0.00% 10.26% 15.95% -92.91% -16.77% -7.88% -20.21% 0.00% 12.67% 7.63% 27.53%
Net Profit -0.96 -5.38 1.97 13.03 11.66 35.11 11.70 23.15 5.65 0.23 6.89 5.33 3.29
EPS in Rs -0.78 -4.36 1.60 10.56 9.45 28.45 8.75 17.32 4.23 0.17 5.15 3.99 2.46
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 TTM
357 401 459 531 455 407 400 372 322 335 544 596 542
267 298 339 393 366 326 349 333 289 295 490 534 501
Operating Profit 89 103 120 138 89 81 51 39 33 41 54 62 41
OPM % 25% 26% 26% 26% 20% 20% 13% 11% 10% 12% 10% 10% 8%
0 0 0 0 1 2 2 2 -3 -4 43 8 9
Interest 19 27 25 29 41 38 34 35 25 13 13 0 0
Depreciation 18 25 33 40 46 42 40 34 34 32 35 34 32
Profit before tax 53 51 63 69 3 4 -22 -28 -30 -8 49 36 18
Tax % 12% 7% 9% 7% -95% 52% 21% -11% 4% -24% -27% -12%
Net Profit 46 47 57 64 5 2 -17 -31 -29 -10 62 41 16
EPS in Rs 50.63 48.33 54.36 56.20 4.51 1.49 -13.84 -24.87 -23.15 -8.10 50.05 30.46 11.77
Dividend Payout % 6% 6% 6% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 4%
5 Years: 8%
3 Years: 23%
TTM: -5%
Compounded Profit Growth
10 Years: -1%
5 Years: 34%
3 Years: 60%
TTM: -71%
Stock Price CAGR
10 Years: -3%
5 Years: 20%
3 Years: 89%
1 Year: -43%
Return on Equity
10 Years: 4%
5 Years: 1%
3 Years: 7%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Sep 2022
9 10 11 11 11 11 12 12 12 12 12 13 13
Reserves 228 289 364 450 445 426 376 350 320 311 374 427 437
187 220 271 289 321 335 312 307 298 220 51 43 42
37 55 72 84 64 70 65 82 102 100 118 97 90
Total Liabilities 461 574 718 834 841 843 765 751 733 644 556 580 583
293 355 401 439 444 452 406 389 364 289 262 241 226
CWIP 15 23 48 68 78 80 66 65 65 25 25 25 25
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
152 196 268 327 319 310 293 297 304 330 269 314 331
Total Assets 461 574 718 834 841 843 765 751 733 644 556 580 583

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
37 42 52 53 68 47 59 31 45 78 132 41
-96 -95 -104 -95 -67 3 -18 8 -11 -5 57 -17
60 53 55 40 -1 -46 -44 -39 -35 -73 -162 -9
Net Cash Flow 1 -0 3 -2 -1 3 -4 0 -1 -0 27 14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Debtor Days 37 36 37 45 51 55 43 46 43 33 21 24
Inventory Days 137 156 178 173 194 219 226 246 286 296 129 119
Days Payable 14 20 26 38 40 38 48 52 72 77 76 51
Cash Conversion Cycle 159 173 190 180 204 236 221 240 257 252 74 91
Working Capital Days 76 88 98 115 146 179 163 144 127 166 74 85
ROCE % 19% 17% 15% 14% 6% 5% 2% 1% 1% 2% 8% 8%

Shareholding Pattern

Numbers in percentages

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
35.89 35.89 35.89 35.89 35.89 40.81 40.81 40.81 40.81 41.76 41.76 41.76
0.04 0.04 0.04 0.04 0.04 0.02 0.10 0.28 0.33 0.96 1.13 1.07
64.07 64.07 64.07 64.07 64.07 59.17 59.09 58.91 58.86 57.28 57.11 57.19

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings